Compare Motilal Oswal Nifty MidSmall Healthcare Index Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹500
₹500
Expense Ratio
1.15
1.93
NAV
₹10.42
₹428.69
Fund Started
29 Oct 2024
04 Jun 1999
Fund Size
₹26.71 Cr
₹3822.73 Cr
Exit Load
Exit load of 1%, if redeemed within 15 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
10.75%
7.42%
3 Year
-
25.82%
5 Year
-
17.14%
Equity
99.73%
98.53%
Cash
0.27%
1.39%
Top 10 Holdings
Lupin Ltd. | 10.09% |
Fortis Healthcare Ltd. | 8.57% |
Laurus Labs Ltd. | 7.24% |
Aurobindo Pharma Ltd. | 6.53% |
Alkem Laboratories Ltd. | 6.42% |
Glenmark Pharmaceuticals Ltd. | 5.87% |
Biocon Ltd. | 5.06% |
Mankind Pharma Ltd. | 4.64% |
Ipca Laboratories Ltd. | 3.95% |
JB Chemicals & Pharmaceuticals Ltd. | 2.95% |
Sun Pharmaceutical Industries Ltd. | 10.02% |
Divi's Laboratories Ltd. | 6.96% |
Apollo Hospitals Enterprise Ltd. | 5.46% |
Max Healthcare Institute Ltd. | 5.01% |
Lupin Ltd. | 4.73% |
Acutaas Chemicals Ltd. | 4.50% |
Torrent Pharmaceuticals Ltd. | 4.14% |
Aether Industries Ltd. | 3.67% |
Biocon Ltd. | 3.60% |
Aster DM Healthcare Ltd. | 3.47% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide returns that, before expenses, correspond to the total returns of the securities as represented by Nifty MidSmall Healthcare Total Return Index, subject to tracking error.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
29 Oct 2024
04 Jun 1999
